<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H6D405DD0BE4C4B16A66AEC0B819AE21F" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 4353 IH: Missed Opportunities in Public Health and Biomedical Research Act of 2017</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-11-09</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 4353</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20171109">November 9, 2017</action-date><action-desc><sponsor name-id="L000287">Mr. Lewis of Georgia</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Public Health Service Act to require reporting by the National Institutes of Health on
			 requests for funding research that were not granted and had the greatest
			 potential for improving public health, and for other purposes.</official-title></form>
	<legis-body id="H04C890843AA54A4B97CE4785C24161F0" style="OLC">
 <section id="HEEFA0F6B799247BCA889DC18593E9497" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Missed Opportunities in Public Health and Biomedical Research Act of 2017</short-title></quote>.</text> </section><section id="H377E6D24E20A4FCE8C3EE83AF00DD299"><enum>2.</enum><header>Annual reporting by NIH on missed opportunities</header><text display-inline="no-display-inline">The Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/201">42 U.S.C. 201</external-xref> et seq.) is amended by inserting after section 403D of such Act (<external-xref legal-doc="usc" parsable-cite="usc/42/283a-3">42 U.S.C. 283a–3</external-xref>) the following:</text>
			<quoted-block display-inline="no-display-inline" id="HBA7502FC6ADE4D8E99A35AE3989C4EC4" style="OLC">
				<section id="HFEE9AB9DAC534E00B665E1B2A380DBEA"><enum>403E.</enum><header>Annual reporting on missed opportunities</header>
 <subsection id="HC6D28EE4E56C40F9B187D830AB734250"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than the last day of the first fiscal quarter following the end of each fiscal year, the Director of NIH shall submit a report to Congress identifying, with respect to each national research institute, each national center, and the Office of the Director of NIH—</text>
 <paragraph id="H1C2AD07001E14777AE426E9C3822F139"><enum>(1)</enum><text>the success rate of grant applications reviewed during such fiscal year;</text> </paragraph><paragraph id="H0BEA9C9D2BD649749ED04627CDEF656C"><enum>(2)</enum><text>the top two grant applications reviewed during such fiscal year that were not funded; and</text>
 </paragraph><paragraph id="H0CDF47411F0B49AB91299CCC7E7D38E2"><enum>(3)</enum><text>if the success rate described in paragraph (1) is lower than 32 percent, the top grant applications that were reviewed and could have been funded to achieve a success rate of at least 32 percent.</text>
 </paragraph></subsection><subsection id="H407FB334DA4642B38BF66CD53CFF9B79"><enum>(b)</enum><header>Trade secrets and confidential information</header><text display-inline="yes-display-inline">This section does not authorize the Secretary to disclose any information that is a trade secret or confidential information subject to section 552(b)(4) of title 5, United States Code, or section 1905 of title 18, United States Code.</text>
 </subsection><subsection id="H80330E48F8164BE783471121AB2C96C7"><enum>(c)</enum><header>Definitions</header><text display-inline="yes-display-inline">In this section:</text> <paragraph id="HCCC60AF7078040658A8E4557E2E73C2A"><enum>(1)</enum><text>The term <quote>success rate</quote> means the percentage of grant applications reviewed during the respective fiscal year that received funding.</text>
 </paragraph><paragraph id="HB8EDD59E03364D08B32CDFF0804EB6E9"><enum>(2)</enum><text>The term <quote>top</quote> means having the greatest potential for—</text> <subparagraph id="H9E0446F2EB3042B99DA6E8A84C88891B"><enum>(A)</enum><text>improving public health;</text>
 </subparagraph><subparagraph id="H0E426D2C158B4F25A5E55350F3A530D9"><enum>(B)</enum><text>advancing biomedical and behavioral research; and</text> </subparagraph><subparagraph id="H4DF4AEFA97FA42F1B4CF79A09DECE785"><enum>(C)</enum><text>increasing fundamental knowledge about the nature and behavior of living systems, and the application of that knowledge towards enhancing health, lengthening life, and reducing illness and disability.</text>
							</subparagraph></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
		</section></legis-body></bill>


